Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Clinical and Experimental Metastasis
Journal
Overview
Identity
Overview
Publication Venue For
Automated quantitative image analysis for ex vivo metastasis assays reveals differing lung composition requirements for metastasis suppression by KISS1.
. 35:77-86.
2018
Perspective on the interpretation of research and translation to clinical care with therapy-associated metastatic breast cancer progression as an example.
. 34:443-447.
2017
Genome-wide in vivo RNAi screen identifies ITIH5 as a metastasis suppressor in pancreatic cancer.
. 34:229-239.
2017
MTBP inhibits migration and metastasis of hepatocellular carcinoma.
. 32:301-311.
2015
Diet modulation is an effective complementary agent in preventing and treating breast cancer lung metastasis.
. 31:625-638.
2014
Nuclear localization of Kaiso promotes the poorly differentiated phenotype and EMT in infiltrating ductal carcinomas.
. 31:497-510.
2014
FAK inhibition decreases cell invasion, migration and metastasis in MYCN amplified neuroblastoma.
. 30:555-568.
2013
L1CAM stimulates glioma cell motility and proliferation through the fibroblast growth factor receptor.
. 30:507-520.
2013
NM23 deficiency promotes metastasis in a UV radiation-induced mouse model of human melanoma.
. 30:25-36.
2013
Ubiquitous Brms1 expression is critical for mammary carcinoma metastasis suppression via promotion of apoptosis.
. 29:315-325.
2012
CD44+/CD24- ovarian cancer cells demonstrate cancer stem cell-like properties and correlate to survival.
. 28:400-406.
2012
Gli1 enhances migration and invasion via up-regulation of MMP-11 and promotes metastasis in ERα negative breast cancer cell lines.
. 28:437-449.
2011
KISS1 over-expression suppresses metastasis of pancreatic adenocarcinoma in a xenograft mouse model.
. 27:591-600.
2010
BRMS1 contributes to the negative regulation of uPA gene expression through recruitment of HDAC1 to the NF-kappaB binding site of the uPA promoter.
. 26:229-237.
2009
Dietary stearate reduces human breast cancer metastasis burden in athymic nude mice.
. 26:415-424.
2009
Expression and functional analysis of the WAP four disulfide core domain 1 gene in human melanoma.
. 26:739-749.
2009
Multi-faceted role of HSP40 in cancer.
. 26:559-567.
2009
Multiple forms of BRMS1 are differentially expressed in the MCF10 isogenic breast cancer progression model.
. 26:89-96.
2009
Nuclear magnetic resonance and circular dichroism study of metastin (Kisspeptin-54) structure in solution.
. 26:527-533.
2009
Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer.
. 25:753-763.
2008
Expressing connexin 43 in breast cancer cells reduces their metastasis to lungs.
. 25:893-901.
2008
Syndecan-1: a dynamic regulator of the myeloma microenvironment.
. 25:149-159.
2008
Breast cancer metastasis to bone: evaluation of bioluminescent imaging and microSPECT/CT for detecting bone metastasis in immunodeficient mice.
. 24:389-401.
2007
Microarray analysis reveals potential mechanisms of BRMS1-mediated metastasis suppression.
. 24:551-565.
2007
Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435.
. 23:123-133.
2006
A novel assay for the quantification of invasion from raft cultures of lung carcinomas.
. 21:1-6.
2004
A small molecule antagonist of the alpha(v)beta3 integrin suppresses MDA-MB-435 skeletal metastasis.
. 21:119-128.
2004
Identification of metastasis-associated proteins through protein analysis of metastatic MDA-MB-435 and metastasis-suppressed BRMS1 transfected-MDA-MB-435 cells.
. 21:149-157.
2004
Breast cancer metastasis suppressor 1: update.
. 20:45-50.
2003
Clinical & Experimental Metastasis: Introduction
. 20:187.
2003
Clinical and Experimental Metastasis: Introduction
. 20:1-2.
2003
Effects of alpha-difluoromethylornithine on local recurrence and pulmonary metastasis from MDA-MB-435 breast cancer xenografts in nude mice.
. 20:321-325.
2003
KISS1 metastasis suppression and emergent pathways.
. 20:11-18.
2003
MDA-MB-435 human breast carcinoma metastasis to bone.
. 20:327-334.
2003
The skeleton as a unique environment for breast cancer cells.
. 20:275-284.
2003
B16F10 melanoma cell colonization of mouse lung is enhanced by partial pneumonectomy.
. 19:369-376.
2002
Influence of polyamines on in vitro and in vivo features of aggressive and metastatic behavior by human breast cancer cells.
. 19:95-105.
2002
Analysis of mechanisms underlying BRMS1 suppression of metastasis.
. 18:683-693.
2000
Dipeptidyl peptidase IV (DPPIV) inhibits cellular invasion of melanoma cells.
. 18:391-400.
2000
The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines.
. 18:519-525.
2000
Metastasis-suppressed C8161 melanoma cells arrest in lung but fail to proliferate.
. 17:601-607.
1999
Calcitriol enhancement of TPA-induced tumorigenic transformation is mediated through vitamin D receptor-dependent and -independent pathways.
. 15:580-592.
1997
Suppression of human melanoma metastasis following introduction of chromosome 6 is independent of NME1 (Nm23).
. 15:259-265.
1997
Technical considerations for studying cancer metastasis in vivo.
. 15:272-306.
1997
Epidermal growth factor modulates cell attachment to hyaluronic acid by the cell surface glycoprotein CD44.
. 14:268-276.
1996
In vitro invasiveness of DU-145 human prostate carcinoma cells is modulated by EGF receptor-mediated signals.
. 13:407-419.
1995
U-77,863: a novel cinnanamide isolated from Streptomyces griseoluteus that inhibits cancer invasion and metastasis.
. 11:201-212.
1993
Tumor progression- and metastasis-associated proteins identified using a model of locally recurrent rat mammary adenocarcinomas.
. 8:533-551.
1990
A novel method for selection of invasive tumor cells: derivation and characterization of highly metastatic K1735 melanoma cell lines based on in vitro and in vivo invasive capacity.
. 6:301-318.
1988
Implications of tumor progression on clinical oncology.
. 3:151-188.
1985
Chromosome and DNA analyses of rat 13762NF mammary adenocarcinoma cell lines and clones of different metastatic potentials.
. 2:271-286.
1984
Multiple phenotypic divergence of mammary adenocarcinoma cell clones. I. In vitro and in vivo properties.
. 2:333-355.
1984
Multiple phenotypic divergence of mammary adenocarcinoma cell clones. II. Sensitivity to radiation, hyperthermia and FUdR.
. 2:357-371.
1984
Phenotypic drift and heterogeneity in response of metastatic mammary adenocarcinoma cell clones to adriamycin, 5-fluoro-2'-deoxyuridine and methotrexate treatment in vitro.
. 1:317-325.
1983
Identity
International Standard Serial Number (issn)
0262-0898
Electronic International Standard Serial Number (eissn)
1573-7276